Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Blood Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Blood Protein Testing
1.2.3 Tumor Marker Testing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Tumor Blood Testing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Blood Testing Market Perspective (2018-2033)
2.2 Tumor Blood Testing Growth Trends by Region
2.2.1 Global Tumor Blood Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Tumor Blood Testing Historic Market Size by Region (2018-2023)
2.2.3 Tumor Blood Testing Forecasted Market Size by Region (2024-2033)
2.3 Tumor Blood Testing Market Dynamics
2.3.1 Tumor Blood Testing Industry Trends
2.3.2 Tumor Blood Testing Market Drivers
2.3.3 Tumor Blood Testing Market Challenges
2.3.4 Tumor Blood Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Blood Testing Players by Revenue
3.1.1 Global Top Tumor Blood Testing Players by Revenue (2018-2023)
3.1.2 Global Tumor Blood Testing Revenue Market Share by Players (2018-2023)
3.2 Global Tumor Blood Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tumor Blood Testing Revenue
3.4 Global Tumor Blood Testing Market Concentration Ratio
3.4.1 Global Tumor Blood Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Blood Testing Revenue in 2022
3.5 Tumor Blood Testing Key Players Head office and Area Served
3.6 Key Players Tumor Blood Testing Product Solution and Service
3.7 Date of Enter into Tumor Blood Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Blood Testing Breakdown Data by Type
4.1 Global Tumor Blood Testing Historic Market Size by Type (2018-2023)
4.2 Global Tumor Blood Testing Forecasted Market Size by Type (2024-2033)
5 Tumor Blood Testing Breakdown Data by Application
5.1 Global Tumor Blood Testing Historic Market Size by Application (2018-2023)
5.2 Global Tumor Blood Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Tumor Blood Testing Market Size (2018-2033)
6.2 North America Tumor Blood Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Tumor Blood Testing Market Size by Country (2018-2023)
6.4 North America Tumor Blood Testing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Blood Testing Market Size (2018-2033)
7.2 Europe Tumor Blood Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Tumor Blood Testing Market Size by Country (2018-2023)
7.4 Europe Tumor Blood Testing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Blood Testing Market Size (2018-2033)
8.2 Asia-Pacific Tumor Blood Testing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Tumor Blood Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Tumor Blood Testing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Blood Testing Market Size (2018-2033)
9.2 Latin America Tumor Blood Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Tumor Blood Testing Market Size by Country (2018-2023)
9.4 Latin America Tumor Blood Testing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Blood Testing Market Size (2018-2033)
10.2 Middle East & Africa Tumor Blood Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Tumor Blood Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Tumor Blood Testing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Guardant Health
11.1.1 Guardant Health Company Detail
11.1.2 Guardant Health Business Overview
11.1.3 Guardant Health Tumor Blood Testing Introduction
11.1.4 Guardant Health Revenue in Tumor Blood Testing Business (2018-2023)
11.1.5 Guardant Health Recent Development
11.2 Trovagene
11.2.1 Trovagene Company Detail
11.2.2 Trovagene Business Overview
11.2.3 Trovagene Tumor Blood Testing Introduction
11.2.4 Trovagene Revenue in Tumor Blood Testing Business (2018-2023)
11.2.5 Trovagene Recent Development
11.3 Genomic Health
11.3.1 Genomic Health Company Detail
11.3.2 Genomic Health Business Overview
11.3.3 Genomic Health Tumor Blood Testing Introduction
11.3.4 Genomic Health Revenue in Tumor Blood Testing Business (2018-2023)
11.3.5 Genomic Health Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Tumor Blood Testing Introduction
11.4.4 Roche Revenue in Tumor Blood Testing Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Bio-Techne
11.5.1 Bio-Techne Company Detail
11.5.2 Bio-Techne Business Overview
11.5.3 Bio-Techne Tumor Blood Testing Introduction
11.5.4 Bio-Techne Revenue in Tumor Blood Testing Business (2018-2023)
11.5.5 Bio-Techne Recent Development
11.6 Pathway Genomics
11.6.1 Pathway Genomics Company Detail
11.6.2 Pathway Genomics Business Overview
11.6.3 Pathway Genomics Tumor Blood Testing Introduction
11.6.4 Pathway Genomics Revenue in Tumor Blood Testing Business (2018-2023)
11.6.5 Pathway Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Tumor Blood Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Blood Protein Testing
Table 3. Key Players of Tumor Marker Testing
Table 4. Key Players of Others
Table 5. Global Tumor Blood Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Tumor Blood Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Tumor Blood Testing Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Tumor Blood Testing Market Share by Region (2018-2023)
Table 9. Global Tumor Blood Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Tumor Blood Testing Market Share by Region (2024-2033)
Table 11. Tumor Blood Testing Market Trends
Table 12. Tumor Blood Testing Market Drivers
Table 13. Tumor Blood Testing Market Challenges
Table 14. Tumor Blood Testing Market Restraints
Table 15. Global Tumor Blood Testing Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Tumor Blood Testing Market Share by Players (2018-2023)
Table 17. Global Top Tumor Blood Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Blood Testing as of 2022)
Table 18. Ranking of Global Top Tumor Blood Testing Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Tumor Blood Testing Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Tumor Blood Testing Product Solution and Service
Table 22. Date of Enter into Tumor Blood Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Tumor Blood Testing Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Tumor Blood Testing Revenue Market Share by Type (2018-2023)
Table 26. Global Tumor Blood Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Tumor Blood Testing Revenue Market Share by Type (2024-2033)
Table 28. Global Tumor Blood Testing Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Tumor Blood Testing Revenue Market Share by Application (2018-2023)
Table 30. Global Tumor Blood Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Tumor Blood Testing Revenue Market Share by Application (2024-2033)
Table 32. North America Tumor Blood Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Tumor Blood Testing Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Tumor Blood Testing Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Tumor Blood Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Tumor Blood Testing Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Tumor Blood Testing Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Tumor Blood Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Tumor Blood Testing Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Tumor Blood Testing Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Tumor Blood Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Tumor Blood Testing Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Tumor Blood Testing Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Tumor Blood Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Tumor Blood Testing Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Tumor Blood Testing Market Size by Country (2024-2033) & (US$ Million)
Table 47. Guardant Health Company Detail
Table 48. Guardant Health Business Overview
Table 49. Guardant Health Tumor Blood Testing Product
Table 50. Guardant Health Revenue in Tumor Blood Testing Business (2018-2023) & (US$ Million)
Table 51. Guardant Health Recent Development
Table 52. Trovagene Company Detail
Table 53. Trovagene Business Overview
Table 54. Trovagene Tumor Blood Testing Product
Table 55. Trovagene Revenue in Tumor Blood Testing Business (2018-2023) & (US$ Million)
Table 56. Trovagene Recent Development
Table 57. Genomic Health Company Detail
Table 58. Genomic Health Business Overview
Table 59. Genomic Health Tumor Blood Testing Product
Table 60. Genomic Health Revenue in Tumor Blood Testing Business (2018-2023) & (US$ Million)
Table 61. Genomic Health Recent Development
Table 62. Roche Company Detail
Table 63. Roche Business Overview
Table 64. Roche Tumor Blood Testing Product
Table 65. Roche Revenue in Tumor Blood Testing Business (2018-2023) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Bio-Techne Company Detail
Table 68. Bio-Techne Business Overview
Table 69. Bio-Techne Tumor Blood Testing Product
Table 70. Bio-Techne Revenue in Tumor Blood Testing Business (2018-2023) & (US$ Million)
Table 71. Bio-Techne Recent Development
Table 72. Pathway Genomics Company Detail
Table 73. Pathway Genomics Business Overview
Table 74. Pathway Genomics Tumor Blood Testing Product
Table 75. Pathway Genomics Revenue in Tumor Blood Testing Business (2018-2023) & (US$ Million)
Table 76. Pathway Genomics Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumor Blood Testing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Tumor Blood Testing Market Share by Type: 2022 VS 2033
Figure 3. Blood Protein Testing Features
Figure 4. Tumor Marker Testing Features
Figure 5. Others Features
Figure 6. Global Tumor Blood Testing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Tumor Blood Testing Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Tumor Blood Testing Report Years Considered
Figure 12. Global Tumor Blood Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Tumor Blood Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Tumor Blood Testing Market Share by Region: 2022 VS 2033
Figure 15. Global Tumor Blood Testing Market Share by Players in 2022
Figure 16. Global Top Tumor Blood Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Blood Testing as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Tumor Blood Testing Revenue in 2022
Figure 18. North America Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Tumor Blood Testing Market Share by Country (2018-2033)
Figure 20. United States Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Tumor Blood Testing Market Share by Country (2018-2033)
Figure 24. Germany Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Tumor Blood Testing Market Share by Region (2018-2033)
Figure 32. China Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Tumor Blood Testing Market Share by Country (2018-2033)
Figure 40. Mexico Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Tumor Blood Testing Market Share by Country (2018-2033)
Figure 44. Turkey Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Tumor Blood Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Guardant Health Revenue Growth Rate in Tumor Blood Testing Business (2018-2023)
Figure 47. Trovagene Revenue Growth Rate in Tumor Blood Testing Business (2018-2023)
Figure 48. Genomic Health Revenue Growth Rate in Tumor Blood Testing Business (2018-2023)
Figure 49. Roche Revenue Growth Rate in Tumor Blood Testing Business (2018-2023)
Figure 50. Bio-Techne Revenue Growth Rate in Tumor Blood Testing Business (2018-2023)
Figure 51. Pathway Genomics Revenue Growth Rate in Tumor Blood Testing Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed